Abstract
Hyperhomocysteinemia (HHCY) has been demonstrated to affect cochlear microvasculature as well as cochlear epithelial cells directly, with a resultant alteration of the expression of matrix metalloproteinases (MMPs) and their inhibitors, tissue inhibitors of metalloproteinases (TIMPs). Hence, ascertaining the optimum concentration of MMPs and TIMPs in the cochlea could help to inhibit hearing loss due to HHCY by the administration of appropriate MMP inhibitors, Since infections/inflammations as well as ototoxic antibiotics have a similar mechanism of otic pathology, the cochlear damage they cause could also be similarly prevented.
Similar content being viewed by others
References
du Vigneaud V. Trail of research in sulfur chemistry and metabolism, and related fields. Ithaca: N.Y. Cornell University Press; 1952.
Bhargava S, Parakh R, Manocha A, Ali A, Srivastava LM. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease. Vascular. 2007;15(3):149–53.
McCully KS. Homocysteine theory of arteriosclerosis: development and current status. Atheroscler Rev. 1983;11:157–246.
Tyagi N, Gillespie W, Vacek JC, Sen U, Tyagi SC, Lominadze D. Activation of GABA-A receptor ameliorates homocysteine-induced activation of MMP-9 activation by ERK pathway. J Cell Physiol. 2009;220(1):257–66.
Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA. 1962;48:1014–22.
Page-McCaw A, Ewald AJ, Werb Z. Matrix, metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol. 2007;8:221–33.
Rowe RJ, Weiss SJ. Breaching the basement membrane: who, when and how? Trends Cell Biol. 2008;18:560–74.
Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta. 2010;1803:3–19.
Overall CM, Kleifield O. Tumour microenvironment—opinion: validating matrix metalloproteinases as drug targets for cancer therapy. Nat Rev Cancer. 2006;6:227–39.
Apte SS, Olsen BR, Murphy G. Gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem. 1995;270:14313–8.
Chintala SK. The emerging role of proteases in retinal ganglion cell death. Exp Eye Res. 2006;82:5–12.
Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution and diversification. FASEB J. 1998;12:1075–95.
Chicoine E, Esteve PO, Robledo O, Van Themsche C, Potworowski EF, St-Pierre Y. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun. 2002;297:765–72.
Shukeir N, Pakneshan P, Chen G, Szef M, Rabbani SA. Alteration of the methylation status of the tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res. 2006;66:9202–10.
Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000;1477(1–2):267–83.
Hayden MR, Tyagi SC. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J. 2004;3(1):4.
Gok U, Halifeoglu I, Canatan H, Yildiz M, Gursu MF, Gur B. Comparative analysis of serum homocysteine, folic acid and vitamin B12 levels in patients with noise-induced hearing loss. Auris Nasus Larynx. 2004;31:19–22.
Kundu S, Tyagi N, Sen U, Tyagi SC. Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Mol Cell Biochem. 2009;332(1–2):215–24.
Setz C, Brand Y, Radojevic V, Hanusek C, Mullen PJ, Levano S, et al. Matrix metalloproteinases 2 and 9 in the cochlea: expression and activity after aminoglycoside exposition. Neuroscience. 2011;181:28–39.
Thorne PR, Gavin JB, Herdson PB. A quantitative study of the sequence of topographical changes in the organ of Corti following acoustic trauma. Acta Otolaryngol. 1984;97:69–81.
Hu BH, Cai Q, Hu Z, Patel M, Bard J, Jamison J, et al. Metalloproteinases and their associated genes contribute to the functional integrity and noise-induced damage in the cochlear sensory epithelium. J Neurosci. 2012;32(43):14927–41.
Leib SL, Leppert D, Clements J, Tauber MG. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun. 2000;68:615–20.
Choi CH, Jang CH, Cho YB, Jo SY, Kim MY, Park BY. Matrix metalloproteinase inhibitor attenuates cochlear lateral wall damage induced by intratympanic instillation of endotoxin. Int J Ped Otorhinolaryngol. 2012;76:544–8.
Nam S-II, Kwon TK. Dexamethasone inhibits interleukin-1β-induced matrix metalloproteinase-9 expression in cochlear cells. Clin Exp Otorhinolaryngol. 2012;7(3):175–80.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhargava, S., Bhargava, M.S., Bhargava, E.K. et al. Hyperhomocysteinemia, MMPs and Cochlear Function: A Short Review. Ind J Clin Biochem 31, 148–151 (2016). https://doi.org/10.1007/s12291-015-0505-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-015-0505-1